The increasing interest in effective weight management has resulted in considerable investigation into cutting-edge treatments. Recently , Retatrutide, a combined -action GIP and GLP-1 receptor agonist , has demonstrated positive results in patient trials, implying potential for considerable weight loss . Therefore, numerous individuals are wanting